T1	PROC 44 84	Ensayo fase 3, aleatorizado, doble ciego
T2	PROC 89 102	quimioterapia
#1	AnnotatorNotes T2	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T3	CHEM 107 116	nivolumab
#2	AnnotatorNotes T3	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T4	PROC 126 139	quimioterapia
#3	AnnotatorNotes T4	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T5	PROC 144 151	placebo
#4	AnnotatorNotes T5	C0032042; Placebos; Therapeutic or Preventive Procedure
T6	PROC 165 185	resección quirúrgica
#5	AnnotatorNotes T6	C0728940; Excision; Therapeutic or Preventive Procedure
T7	CHEM 197 206	nivolumab
#6	AnnotatorNotes T7	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T8	PROC 209 216	placebo
#7	AnnotatorNotes T8	C0032042; Placebos; Therapeutic or Preventive Procedure
T9	DISO 257 288	cáncer de pulmón no microcítico
#8	AnnotatorNotes T9	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T10	PROC 331 338	cirugía
#9	AnnotatorNotes T10	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T11	PROC 361 404	Estudio fase 3, aleatorizado, a doble ciego
T12	PROC 409 435	quimioterapia neoadyuvante
T13	CHEM 440 449	nivolumab
#10	AnnotatorNotes T13	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T14	PROC 459 485	quimioterapia neoadyuvante
T15	PROC 490 497	placebo
#11	AnnotatorNotes T15	C0032042; Placebos; Therapeutic or Preventive Procedure
T16	PROC 511 531	resección quirúrgica
#12	AnnotatorNotes T16	C0728940; Excision; Therapeutic or Preventive Procedure
T17	PROC 534 555	tratamiento adyuvante
#13	AnnotatorNotes T17	C0677850; Adjuvant therapy; Therapeutic or Preventive Procedure
T18	PROC 572 579	placebo
#14	AnnotatorNotes T18	C0032042; Placebos; Therapeutic or Preventive Procedure
T19	DISO 601 632	cáncer de pulmón no microcítico
#15	AnnotatorNotes T19	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T20	PROC 702 731	evaluación del ensayo clínico
T21	CHEM 740 749	nivoluMAb
#16	AnnotatorNotes T21	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T22	ANAT 783 789	pulmón
#17	AnnotatorNotes T22	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T23	DISO 773 804	Cancer de pulmón no microcítico
#18	AnnotatorNotes T23	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T24	PROC 845 852	cirugía
#19	AnnotatorNotes T24	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T25	ANAT 888 894	pulmón
#20	AnnotatorNotes T25	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T26	DISO 878 909	Cancer de pulmón no microcítico
#21	AnnotatorNotes T26	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T27	DISO 1019 1023	CPNM
#22	AnnotatorNotes T27	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T28	DISO 986 1017	Cancer de Pulmon no microcitico
#23	AnnotatorNotes T28	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T29	DISO 1092 1102	enfermedad
#24	AnnotatorNotes T29	C0012634; Disease; Disease or Syndrome
T30	DISO 1132 1153	metástasis cerebrales
#25	AnnotatorNotes T30	C0220650; Metastatic malignant neoplasm to brain; Neoplastic Process | C0555278; Cerebral metastasis; Neoplastic Process
T31	PROC 1165 1176	tratamiento
#26	AnnotatorNotes T31	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T32	PROC 1182 1220	tratamiento anti cancerígeno sistémico
T33	ANAT 996 1002	Pulmon
#27	AnnotatorNotes T33	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T34	ANAT 1265 1279	tejido tumoral
T35	PROC 1294 1301	cirugía
#28	AnnotatorNotes T35	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T36	PROC 1304 1311	biopsia
#29	AnnotatorNotes T36	C0005558; Biopsy; Diagnostic Procedure
T37	PROC 1317 1341	estudio de biomarcadores
T38	PROC 1407 1416	protocolo
#30	AnnotatorNotes T38	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T39	PROC 1465 1481	ensayos clínicos
#31	AnnotatorNotes T39	C0008976; Clinical Trials; Research Activity
T40	DISO 1598 1619	enfermedad autoinmune
#32	AnnotatorNotes T40	C0004364; Autoimmune Diseases; Disease or Syndrome
T41	PROC 1663 1667	test
#33	AnnotatorNotes T41	C0022885; Laboratory Procedures; Laboratory Procedure
T42	DISO 1730 1755	infección aguda o crónica
T43	PROC 1768 1796	tratamiento anti cancerígeno
T44	CHEM 1815 1834	agentes citotóxicos
#34	AnnotatorNotes T44	C0304497; Cytotoxic agent; Pharmacologic Substance
T45	PROC 1836 1862	Tratamiento inmunoterápico
T46	PROC 1864 1882	terapias dirigidas
#35	AnnotatorNotes T46	C0278348; Immunotherapy for cancer; Therapeutic or Preventive Procedure
T47	PROC 1885 1897	radioterapia
#36	AnnotatorNotes T47	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T48	PROC 1962 1971	protocolo
#37	AnnotatorNotes T48	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T49	PROC 2019 2035	ensayos clínicos
#38	AnnotatorNotes T49	C0008976; Clinical Trials; Research Activity
T50	PROC 228 235	cirugía
#39	AnnotatorNotes T50	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T51	ANAT 267 273	pulmón
#40	AnnotatorNotes T51	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T52	ANAT 277 288	microcítico
#41	AnnotatorNotes T52	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T53	CHEM 560 569	nivolumab
#42	AnnotatorNotes T53	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T54	ANAT 611 617	pulmón
#43	AnnotatorNotes T54	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T55	ANAT 621 632	microcítico
#44	AnnotatorNotes T55	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T56	ANAT 793 804	microcítico
#45	AnnotatorNotes T56	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T57	ANAT 898 909	microcítico
#46	AnnotatorNotes T57	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T58	ANAT 1143 1153	cerebrales
#47	AnnotatorNotes T58	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T59	DISO 1272 1279	tumoral
#48	AnnotatorNotes T59	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T60	ANAT 1006 1017	microcitico
#49	AnnotatorNotes T60	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T61	DISO 1685 1711	virus de la hepatitis B, C
T62	DISO 1714 1717	VIH
#50	AnnotatorNotes T62	C0458074; Human immunodeficiency virus (HIV) status; Finding
T63	Date 12 16	2019
T64	Neg_cue 274 276	no
T66	Neg_cue 618 620	no
T67	Neg_cue 790 792	no
T69	Neg_cue 895 897	no
T70	Neg_cue 1003 1005	no
T71	Spec_cue 1077 1087	sospechado
T72	Neg_cue 1128 1131	Sin
T73	Neg_cue 1156 1164	Naive al
T74	Neg_cue 1178 1181	sin
T77	Spec_cue 1639 1649	sospechada
T80	Duration 1748 1755	crónica
#51	AnnotatorNotes T80	C0205191; chronic; Temporal Concept
T65	LIVB 239 252	participantes
#52	AnnotatorNotes T65	C4554048; Study Participant; Population Group
T68	LIVB 583 596	participantes
#53	AnnotatorNotes T68	C4554048; Study Participant; Population Group
T75	LIVB 1576 1589	Participantes
#54	AnnotatorNotes T75	C4554048; Study Participant; Population Group
T76	LIVB 968 981	Participantes
#55	AnnotatorNotes T76	C4554048; Study Participant; Population Group
T78	PROC 1058 1074	histológicamente
#56	AnnotatorNotes T78	C0344441; Histology Procedure; Laboratory Procedure
A1	Assertion T52 Negated
A2	Assertion T55 Negated
A3	Assertion T56 Negated
A4	Assertion T57 Negated
A5	Assertion T60 Negated
A6	Assertion T28 Speculated
A7	Assertion T30 Negated
A8	Status T31 History_of
A9	Assertion T31 Negated
A10	Status T32 History_of
A11	Assertion T32 Negated
A14	Assertion T40 Speculated
A13	Assertion T27 Speculated
A12	Status T40 History_of
A15	Status T43 History_of
A16	Status T44 History_of
A17	Status T45 History_of
A18	Status T46 History_of
A19	Status T47 History_of
#57	AnnotatorNotes T1	C0282461; Phase 3 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity
#58	AnnotatorNotes T11	C0282461; Phase 3 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity
#59	AnnotatorNotes T14	C5392214; Neoadjuvant Chemotherapy; Therapeutic or Preventive Procedure
#60	AnnotatorNotes T12	C5392214; Neoadjuvant Chemotherapy; Therapeutic or Preventive Procedure
#61	AnnotatorNotes T34	C0475358; Tumor tissue sample; Tissue
#62	AnnotatorNotes T37	C1879847; Biomarker Analysis; Laboratory Procedure
#63	AnnotatorNotes T61	C0019163; Hepatitis B; Disease or Syndrome + C0019196; Hepatitis C; Disease or Syndrome
#64	AnnotatorNotes T42	C0151317; Chronic Infection; Disease or Syndrome + C0275518; Acute infectious disease; Disease or Syndrome
#65	AnnotatorNotes T43	C0920425; cancer treatment; Therapeutic or Preventive Procedure
#66	AnnotatorNotes T45	C0021083; Immunotherapy; Therapeutic or Preventive Procedure
T79	Spec_cue 1898 1905	Podrían
T81	Quantifier_or_Qualifier 1916 1921	otros
A20	Assertion T81 Speculated
T82	CONC 1922 1944	criterios de exclusión
A21	Assertion T82 Speculated
#67	AnnotatorNotes T82	C0680251; Exclusion Criteria; Functional Concept
T83	Spec_cue 1344 1351	Podrían
T84	CONC 1368 1390	criterios de inclusión
A22	Assertion T84 Speculated
#68	AnnotatorNotes T84	C1512693; Inclusion Criteria; Qualitative Concept
T85	Quantifier_or_Qualifier 1362 1367	otros
A23	Assertion T85 Speculated
R1	Negation Arg1:T64 Arg2:T52	
R2	Negation Arg1:T66 Arg2:T55	
R3	Negation Arg1:T69 Arg2:T57	
R4	Negation Arg1:T67 Arg2:T56	
R5	Negation Arg1:T70 Arg2:T60	
R6	Speculation Arg1:T71 Arg2:T27	
R7	Speculation Arg1:T71 Arg2:T28	
R8	Negation Arg1:T72 Arg2:T30	
R9	Negation Arg1:T73 Arg2:T31	
R10	Negation Arg1:T74 Arg2:T32	
R11	Speculation Arg1:T83 Arg2:T85	
R12	Speculation Arg1:T83 Arg2:T84	
R13	Has_Quantifier_or_Qualifier Arg1:T84 Arg2:T85	
R14	Speculation Arg1:T77 Arg2:T40	
R15	Speculation Arg1:T79 Arg2:T81	
R16	Speculation Arg1:T79 Arg2:T82	
R17	Has_Quantifier_or_Qualifier Arg1:T82 Arg2:T81	
R18	Combined_with Arg1:T2 Arg2:T3	
R19	Combined_with Arg1:T4 Arg2:T5	
R20	Before Arg1:T2 Arg2:T6	
R21	Before Arg1:T4 Arg2:T6	
R22	Before Arg1:T6 Arg2:T7	
R23	Before Arg1:T6 Arg2:T8	
R24	After Arg1:T8 Arg2:T50	
R25	After Arg1:T7 Arg2:T50	
R26	Experiences Arg1:T65 Arg2:T2	
R27	Experiences Arg1:T65 Arg2:T4	
R28	Experiences Arg1:T65 Arg2:T6	
R29	Experiences Arg1:T65 Arg2:T7	
R30	Experiences Arg1:T65 Arg2:T8	
R31	Experiences Arg1:T65 Arg2:T50	
R32	Experiences Arg1:T65 Arg2:T9	
R33	Experiences Arg1:T65 Arg2:T10	
R34	Combined_with Arg1:T12 Arg2:T13	
R35	Combined_with Arg1:T14 Arg2:T15	
R36	Before Arg1:T12 Arg2:T16	
R37	Combined_with Arg1:T16 Arg2:T17	
R38	Used_for Arg1:T53 Arg2:T17	
R39	Combined_with Arg1:T16 Arg2:T18	
R40	Before Arg1:T14 Arg2:T16	
R41	Experiences Arg1:T68 Arg2:T12	
R42	Experiences Arg1:T68 Arg2:T14	
R43	Experiences Arg1:T68 Arg2:T16	
R44	Experiences Arg1:T68 Arg2:T19	
R45	Location_of Arg1:T54 Arg2:T19	
R46	Location_of Arg1:T51 Arg2:T9	
T86	Quantifier_or_Qualifier 636 651	estadio II-IIIB
R47	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T86	
T87	Quantifier_or_Qualifier 653 662	resecable
#69	AnnotatorNotes T87	C1514888; Resectable; Qualitative Concept
R48	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T87	
T88	Quantifier_or_Qualifier 289 338	que puede ser eliminado completamente por cirugía
#70	AnnotatorNotes T88	C1514888; Resectable; Qualitative Concept
R49	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T88	
R50	Experiences Arg1:T68 Arg2:T21	
R51	Used_for Arg1:T21 Arg2:T17	
T89	Quantifier_or_Qualifier 806 852	que puede eliminarse completamente por cirugía
#71	AnnotatorNotes T89	C1514888; Resectable; Qualitative Concept
R52	Location_of Arg1:T22 Arg2:T23	
R53	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T89	
R54	Location_of Arg1:T25 Arg2:T26	
T90	Quantifier_or_Qualifier 930 939	resecable
#72	AnnotatorNotes T90	C1514888; Resectable; Qualitative Concept
R55	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T90	
T91	Quantifier_or_Qualifier 914 928	estadio II-III
R56	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T91	
R57	Location_of Arg1:T58 Arg2:T30	
R58	Location_of Arg1:T33 Arg2:T28	
R59	Experiences Arg1:T76 Arg2:T28	
R60	Experiences Arg1:T76 Arg2:T27	
T92	Quantifier_or_Qualifier 1028 1046	estadío IIA a IIIB
R62	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T92	
R63	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T92	
T93	Quantifier_or_Qualifier 1115 1124	resecable
#73	AnnotatorNotes T93	C1514888; Resectable; Qualitative Concept
R66	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T93	
R67	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T93	
R68	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T93	
R69	Experiences Arg1:T76 Arg2:T78	
R70	Experiences Arg1:T76 Arg2:T29	
T94	CONC 1231 1235	ECOG
#74	AnnotatorNotes T94	C1520224; ECOG performance status; Intellectual Product
T95	Result_or_Value 1236 1239	≤ 1
R71	Has_Result_or_Value Arg1:T94 Arg2:T95	
R73	Location_of Arg1:T34 Arg2:T37	
R76	Experiences Arg1:T75 Arg2:T40	
T96	Quantifier_or_Qualifier 1620 1626	activa
#75	AnnotatorNotes T96	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R77	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T96	
R81	Has_Duration_or_Interval Arg1:T42 Arg2:T80	
T97	Result_or_Value 1668 1676	positivo
#76	AnnotatorNotes T97	C1446409; Positive; Finding
R82	Has_Result_or_Value Arg1:T41 Arg2:T97	
R83	Causes Arg1:T61 Arg2:T97	
R84	Causes Arg1:T62 Arg2:T97	
R85	Causes Arg1:T42 Arg2:T97	
R86	Used_for Arg1:T44 Arg2:T43	
R61	Location_of Arg1:T33 Arg2:T27	
R87	Location_of Arg1:T33 Arg2:T29	
R88	Before Arg1:T35 Arg2:T37	
R89	Before Arg1:T36 Arg2:T37	
#77	AnnotatorNotes T85	C0205394; Other; Qualitative Concept
#78	AnnotatorNotes T81	C0205394; Other; Qualitative Concept
A24	Experiencer T65 Patient
A25	Experiencer T68 Patient
A26	Experiencer T76 Patient
A27	Experiencer T75 Patient
